Immunogenicity and Safety Study in Infants of GlaxoSmithKline Biologicals' Infanrix Hexa™ (DTPa-HBV-IPV/Hib) Vaccine
Conditions:   Diphtheria;   Hepatitis B;   Haemophilus Influenzae Type b Disease;   Poliomyelitis;   Pertussis;   TetanusIntervention:   Biological: Infanrix hexa™Sponsors:   GlaxoSmithKline;   GlaxoSmithKlineActive, not recruiting - verified January 2013 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 12, 2011 Category: Research Source Type: clinical trials

Immunogenicity and Safety Study in Infants of GlaxoSmithKline Biologicals' Infanrix Hexa™ (DTPa-HBV-IPV/Hib) Vaccine
Conditions:   Poliomyelitis;   Tetanus;   Acellular Pertussis;   Haemophilus Influenzae Type b;   Diphtheria;   Hepatitis BIntervention:   Biological: Infanrix hexa™Sponsor:   GlaxoSmithKlineCompleted - verified April 2013 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 12, 2011 Category: Research Source Type: clinical trials

NeisVac-C Single Prime Study in Infants
Condition:   Neisseria MeningitidisInterventions:   Biological: Meningococcal group C polysaccharide conjugate vaccine;   Biological: Pneumococcal 13-valent conjugate vaccine;   Biological: Combined Diphtheria-Tetanus-acellular Pertussis (DTPa), Hepatitis B, Poliovirus and Haemophilus influenzae type b vaccineSponsor:   PfizerCompleted - verified May 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 8, 2010 Category: Research Source Type: clinical trials

Consistency & Immunogenicity Study of 3 Lots of GSK's Hib Conjugate Vaccine Versus ActHIB & Pentacel in Healthy Infants
Condition:   Haemophilus Influenzae Type bInterventions:   Biological: GSK Biologicals' Haemophilus influenzae type b vaccine (GSK 208108);   Biological: ActHIB™;   Biological: Pentacel™;   Biological: Pediarix™;   Biological: Prevnar 13™;   Biological: Rotarix™;   Biological: Engerix™-B;   Biological: Infanrix™Sponsor:   GlaxoSmithKlineCompleted - verified April 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 22, 2009 Category: Research Source Type: clinical trials

Consistency & Immunogenicity Study of 3 Lots of GSK's Hib Conjugate Vaccine Versus ActHIB & Pentacel in Healthy Infants
Condition:   Haemophilus Influenzae Type bInterventions:   Biological: GSK Biologicals' Haemophilus influenzae type b vaccine (GSK 208108);   Biological: ActHIB™;   Biological: Pentacel™;   Biological: Pediarix™;   Biological: Prevnar 13™;   Biological: Rotarix™;   Biological: Engerix™-B;   Biological: Infanrix™Sponsor:   GlaxoSmithKlineCompleted - verified October 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 22, 2009 Category: Research Source Type: clinical trials